INTRODUCTION: Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life. METHODS AND MATERIALS: A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancer patients, more than 6 months after radiotherapy and without evidence of disease. RESULTS: The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy. CONCLUSIONS: Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.
INTRODUCTION:Xerostomia is a common complication of radiotherapy for head and neck cancer because irreparable damage is caused to the salivary glands if they are included in the radiation fields. The aim of the study was to evaluate the degree of xerostomia in survivors of head and neck cancer and to determine its impact on quality of life. METHODS AND MATERIALS: A xerostomia questionnaire consisting of three parts (xerostomia score, quality of life survey, and visual analogue scale) was completed by 75 head and neck cancerpatients, more than 6 months after radiotherapy and without evidence of disease. RESULTS: The majority of patients (93%) suffered from a dry mouth, and 65% had moderate to severe xerostomia (grade 2 to 3). Both dysphagia (65%) and taste loss (63%) were common, although oral pain was less frequent (33%). The emotional impact of xerostomia was significant, causing worry (64%), tension (61%), or feelings of depression (44%). Furthermore, patients reported problems with talking to (60%) or eating with (54%) other people and to feel restricted in amount and type of food (65%). Quality of life was influenced by T classification, clinical stage, a higher radiation dose or the use of concomitant chemotherapy, but was independent of the interval since the end of radiotherapy. CONCLUSIONS:Xerostomia after radiotherapy for head and neck cancer is extremely common and significantly affects quality of life. No recuperation is seen over time, and the use of concomitant chemotherapy significantly increases the oral complications of radiation. These results warrant the continuing efforts put into the development of salivary gland-sparing radiotherapy techniques and effective treatments of radiation-induced xerostomia.
Authors: Judith M Roesink; Maria Schipper; Wim Busschers; Cornelis P J Raaijmakers; Chris H J Terhaard Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-20 Impact factor: 7.038
Authors: L B Harrison; M J Zelefsky; D G Pfister; E Carper; A Raben; D H Kraus; E W Strong; A Rao; H Thaler; T Polyak; R Portenoy Journal: Head Neck Date: 1997-05 Impact factor: 3.147
Authors: F van Acker; P Flamen; P Lambin; A Maes; G J Kutcher; C Weltens; R Hermans; J Baetens; P Dupont; A Rijnders; A Maes; W van den Bogaert; L Mortelmans Journal: Nucl Med Commun Date: 2001-02 Impact factor: 1.690
Authors: Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun Journal: CA Cancer J Clin Date: 2006 Mar-Apr Impact factor: 508.702
Authors: Annelies Maes; Caroline Weltens; Patrick Flamen; Philippe Lambin; Ria Bogaerts; Xuan Liu; Jan Baetens; Robert Hermans; Walter Van den Bogaert Journal: Radiother Oncol Date: 2002-05 Impact factor: 6.280
Authors: Gwen Wyatt; Stephanie L Pugh; Raimond K W Wong; Stephen Sagar; Anurag K Singh; Shlomo A Koyfman; Phuc F Nguyen-Tân; Sue S Yom; Francis S Cardinale; Khalil Sultanem; Ian Hodson; Greg A Krempl; Barbara Lukaszczyk; Alexander M Yeh; Lawrence Berk Journal: Qual Life Res Date: 2016-02-25 Impact factor: 4.147
Authors: Gabriele Röhrig; Schmidt Pia; Michael Bussmann; Henning Kunter; Michael Johannes Noack; Anna Greta Barbe Journal: Eur Geriatr Med Date: 2020-03-13 Impact factor: 1.710
Authors: Chandylen L Nightingale; Deidre B Pereira; Barbara A Curbow; John R Wingard; Giselle D Carnaby Journal: Biol Res Nurs Date: 2016-07-28 Impact factor: 2.522